ProQR Therapeutics NV
NASDAQ:PRQR

Watchlist Manager
ProQR Therapeutics NV Logo
ProQR Therapeutics NV
NASDAQ:PRQR
Watchlist
Price: 1.2 USD 6.19% Market Closed
Market Cap: 126.3m USD

Intrinsic Value

The intrinsic value of one PRQR stock under the Base Case scenario is hidden USD. Compared to the current market price of 1.2 USD, ProQR Therapeutics NV is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

PRQR Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
ProQR Therapeutics NV

PRQR
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for PRQR cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PRQR?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about ProQR Therapeutics NV
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
ProQR Therapeutics NV

Current Assets 153.8m
Cash & Short-Term Investments 149.4m
Receivables 1.3m
Other Current Assets 3.1m
Non-Current Assets 14.1m
PP&E 14.1m
Efficiency

Free Cash Flow Analysis
ProQR Therapeutics NV

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
ProQR Therapeutics NV

Revenue
19.5m EUR
Operating Expenses
-50m EUR
Operating Income
-30.5m EUR
Other Expenses
2.7m EUR
Net Income
-27.8m EUR
Fundamental Scores

PRQR Profitability Score
Profitability Due Diligence

ProQR Therapeutics NV's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional 1-Year Revenue Growth
ROE is Increasing
ROIC is Increasing
hidden
Profitability
Score

ProQR Therapeutics NV's profitability score is hidden . The higher the profitability score, the more profitable the company is.

PRQR Solvency Score
Solvency Due Diligence

ProQR Therapeutics NV's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Negative Net Debt
Short-Term Solvency
Low D/E
Long-Term Solvency
hidden
Solvency
Score

ProQR Therapeutics NV's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PRQR Price Targets Summary
ProQR Therapeutics NV

Wall Street analysts forecast PRQR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRQR is 9.69 USD with a low forecast of 4.04 USD and a high forecast of 15.75 USD.

Lowest
Price Target
4.04 USD
237% Upside
Average
Price Target
9.69 USD
708% Upside
Highest
Price Target
15.75 USD
1 213% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

ProQR Therapeutics NV
does not pay dividends
Shareholder Yield

Current shareholder yield for PRQR is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN
What is the Intrinsic Value of one PRQR stock?

The intrinsic value of one PRQR stock under the Base Case scenario is hidden USD.

Is PRQR stock undervalued or overvalued?

Compared to the current market price of 1.2 USD, ProQR Therapeutics NV is hidden .

Back to Top